C4 Therapeutics, Inc.
USD3.96
-0.38 (-8.76%)
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.22
Prev. Close
$4.34
Day Low
$3.90
Day High
$4.30
52W Low
$1.36
52W High
$4.60
Market Cap
$0.33B
Volume
1.99M
| 5,370 |
| $2.70 |
| 18 Feb 2026 | Boyle Scott N | Chief Business Officer | F-InKind | Disposed | 7,269 | $1.89 |
| 18 Feb 2026 | Boyle Scott N | Chief Business Officer | F-InKind | Disposed | 1,735 | $1.89 |
| 18 Feb 2026 | Boyle Scott N | Chief Business Officer | M-Exempt | Acquired | 20,950 | $0.00 |
| 18 Feb 2026 | Boyle Scott N | Chief Business Officer | A-Award | Acquired | 200,000 | $0.00 |
| 18 Feb 2026 | Boyle Scott N | Chief Business Officer | M-Exempt | Acquired | 5,000 | $0.00 |
| 18 Feb 2026 | Mahaney Paige | Chief Scientific Officer | A-Award | Acquired | 240,000 | $0.00 |
| 18 Feb 2026 | Mahaney Paige | Chief Scientific Officer | M-Exempt | Acquired | 7,050 | $0.00 |
| 18 Feb 2026 | Mahaney Paige | Chief Scientific Officer | F-InKind | Disposed | 2,446 | $1.89 |